You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Viral status, immune microenvironment and immunological response to checkpoint inhibitors in hepatocellular carcinoma

Article metrics

Article menu

Download PDFPDF

XML
Clinical/translational cancer immunotherapy
Original research
Viral status, immune microenvironment and immunological response to checkpoint inhibitors in hepatocellular carcinoma

 

Online download statistics by month:

Online download statistics by month: April 2020 to January 2026

AbstractFullPdf
Apr 2020545545241
May 2020368368136
Jun 202016216247
Jul 2020999943
Aug 2020454551
Sep 2020929273
Oct 2020747454
Nov 2020838248
Dec 2020727240
Jan 2021646430
Feb 2021606044
Mar 2021686831
Apr 2021747448
May 2021545452
Jun 2021949483
Jul 2021868677
Aug 202111711787
Sep 202110110174
Oct 2021113112107
Nov 202110210281
Dec 2021828265
Jan 2022869154
Feb 2022666965
Mar 2022828880
Apr 2022758158
May 2022888959
Jun 2022727441
Jul 2022676964
Aug 2022838471
Sep 2022949887
Oct 2022869175
Nov 2022717359
Dec 2022686852
Jan 2023444533
Feb 2023929246
Mar 2023757665
Apr 2023505038
May 2023485043
Jun 2023474730
Jul 2023616152
Aug 2023434339
Sep 2023484822
Oct 2023444524
Nov 2023545431
Dec 2023393934
Jan 2024525342
Feb 2024585829
Mar 2024616174
Apr 2024474744
May 2024303029
Jun 2024434432
Jul 2024474821
Aug 2024444426
Sep 2024444431
Oct 2024393930
Nov 2024676857
Dec 2024959666
Jan 2025878756
Feb 202515115166
Mar 2025777755
Apr 202510610743
May 2025646450
Jun 2025909026
Aug 2025110
Oct 2025200
Jan 2026100
Total534453873511